ERBB2 and breast carcinoma: Compared to ER-positive breast cancer, HER2-positive breast cancer and TNBC show higher levels of glutamate and lower levels of glutamine (Masisi et al., 2021), suggesting that these subtypes may have higher glutamine influx and active glutaminolysis.